×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PYXS – pyxis oncology, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PYXS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
10:21 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its price target raised by analysts at Royal Bank of Canada from $7.00 to $10.00. They now have an "outperform" rating on the stock.
Low
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its price target raised by analysts at Royal Bank of Canada from $7.00 to $10.00. They now have an "outperform" rating on the stock.
11/21
08:05 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
11/21
08:05 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
11/20
04:10 pm
pyxs
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data [Yahoo! Finance]
High
Report
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data [Yahoo! Finance]
11/20
04:05 pm
pyxs
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
High
Report
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
11/12
07:30 am
pyxs
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
Low
Report
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
11/11
07:00 am
pyxs
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
Medium
Report
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
11/8
01:38 pm
pyxs
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside [Yahoo! Finance]
Low
Report
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
04:08 pm
pyxs
Form 8-K Pyxis Oncology, Inc. For: Nov 20
High
Report
Form 8-K Pyxis Oncology, Inc. For: Nov 20
11/12
04:38 pm
pyxs
Form S-8 Pyxis Oncology, Inc.
Medium
Report
Form S-8 Pyxis Oncology, Inc.
11/12
11:54 am
pyxs
Form SC 13G/A Pyxis Oncology, Inc. Filed by: Laurion Capital Management LP
Medium
Report
Form SC 13G/A Pyxis Oncology, Inc. Filed by: Laurion Capital Management LP
11/12
09:40 am
pyxs
Form 8-K Pyxis Oncology, Inc. For: Nov 12
Low
Report
Form 8-K Pyxis Oncology, Inc. For: Nov 12
11/12
09:35 am
pyxs
Form 10-Q Pyxis Oncology, Inc. For: Sep 30
Low
Report
Form 10-Q Pyxis Oncology, Inc. For: Sep 30
11/6
04:37 pm
pyxs
Form SC 13G/A Pyxis Oncology, Inc. Filed by: Bayer World Investments B.V.
Low
Report
Form SC 13G/A Pyxis Oncology, Inc. Filed by: Bayer World Investments B.V.
10/23
04:54 pm
pyxs
Form 8-K Pyxis Oncology, Inc. For: Oct 23
Medium
Report
Form 8-K Pyxis Oncology, Inc. For: Oct 23
9/25
04:09 pm
pyxs
Form DEF 14A Pyxis Oncology, Inc. For: Sep 25
Medium
Report
Form DEF 14A Pyxis Oncology, Inc. For: Sep 25
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: